Nuclear receptors in inflammation control: Repression by GR and beyond
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Inflammation is a protective response of organisms to pathogens, irritation or injury. Primary inflammatory sensors activate an array of signaling pathways that ultimately converge upon a few transcription factors such as AP1, NFκB and STATs that in turn stimulate expression of inflammatory genes to ultimately eradicate infection and repair the damage. A disturbed balance between activation and inhibition of inflammatory pathways can set the stage for chronic inflammation which is increasingly recognized as a key pathogenic component of autoimmune, metabolic, cardiovascular and neurodegenerative disorders. Nuclear Receptors (NRs) are a large family of transcription factors many of which are known for their potent anti-inflammatory actions. Activated by small lipophilic ligands, NRs interact with a wide range of transcription factors, cofactors and chromatin-modifying enzymes, assembling numerous cell- and tissue-specific DNA-protein transcriptional regulatory complexes with diverse activities. Here we discuss established and emerging roles and mechanisms by which NRs and, in particular, the glucocorticoid receptor (GR) repress genes encoding cytokines, chemokines and other pro-inflammatory mediators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Neutrophils and immunity: challenges and opportunities
Nathan, C. (2006) · Nature reviews. Immunology · doi:10.1038/nri1785 · Cited by 2,971 · cited 2×
“, defensins, cathepsins, lactoferrin) and reactive oxygen and nitrogen species ultimately aimed at clearing the infection and initiating tissue repair (Nathan 2006).”
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733 · cited 1×
“It has been proposed that the NCoRdependent repression by PPARγ is protective against inflammation-induced insulin resistance associated with obesity and type-II diabetes (Olefsky and Glass 2010).”
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Estrogen receptors: how do they signal and what are their targets
Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., et al. (2007) · Physiological Reviews · doi:10.1152/physrev.00026.2006 · Cited by 1,857
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
Yang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553 · cited 2×
“GR interactions with AP-1 The first evidence of GR-mediated antagonism of AP-1 activity emerged two decades ago when GR activation was shown to inhibit transcription from transfected AP-1 reporters (Jonat, et al. 1990; Yang-Yen et al. 1990).”
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Cited by
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Daruich, A., Matet, A., Dirani, A., Bousquet, E., Zhao, M., Farman, N., Jaisser, F., & Behar-Cohen, F. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.05.003 · Cited by 989
PPARgamma in Metabolism, Immunity, and Cancer: Unified and Diverse Mechanisms of Action
Hernandez-Quiles, M., Broekema, M. F., & Kalkhoven, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.624112 · Cited by 433
Areas of controversy in neuroprogression in bipolar disorder
Passos, I. C., Mwangi, B., Vieta, E., Berk, M., & Kapczinski, F. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12581 · Cited by 208
“Cortisol has antiinflammatory properties based on the effects of the glucocorticoid receptor (GR), which inhibits nuclear factor kappa B and thus reduces the synthesis of proinflammatory cytokines (136).”
BackgroundInflammation in Parkinson’s disease: role of glucocorticoids
Herrero, M.-T., Estrada, C., Maatouk, L., & Vyas, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00032 · Cited by 175
“…PD patients has consistently shown significantly elevated levels compared to age-matched control subjects, and as well correlating with impulsive behaviors (Bellomo et al., 1991; Stypula et al., 1996; Hartmann et al., 1997; Charlett et al., 1998; Djamshidian et al., 2011; Ros-Bernal et al., 2011).”
ResultGlucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle
Gupte, R., Muse, G. W., Chinenov, Y., Adelman, K., & Rogatsky, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309898110 · Cited by 70
“Because of the fundamental role of this process in inflammation control, the molecular basis of GR transrepression has been a subject of intense investigation (20).”
BackgroundSelf-citationSasse, S. K., Gruca, M., Allen, M. A., Kadiyala, V., Song, T., Gally, F., Gupta, A., Pufall, M. A., Dowell, R. D., & Gerber, A. N. (2019) · Genome Research · doi:10.1101/gr.248187.119 · Cited by 44
Metadata
- Authors
- Chinenov, Y., Gupte, R., & Rogatsky, I.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2013-11
- Volume
- 380
- Issue
- 1-2
- Pages
- 55-64
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W1983191249
- Cited by
- 61
- References
- 35
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.